PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Oncology, Antwerp University Hospital Antwerp, Antwerp, Belgium. marika.rasschaert@uza.be.\', \'Department of Oncology, Antwerp University Hospital Antwerp, Antwerp, Belgium.\', \'Clinical Trials Center (CTC), CRC Antwerp, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.\', \'Department of Information and Communication Technology, Antwerp University Hospital, Antwerp, Belgium.\', \'Department of Haematology, Antwerp University Hospital, Antwerp, Belgium.\', \'BVBA Remedus, Aartselaar, Belgium.\', \'Department of Thoracic Oncology, Antwerp University Hospital, Antwerp, Belgium.\', \'Unit of Gynecologic Oncology, Department of Obstetrics & Gynecology, Antwerp University Hospital, Antwerp, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41416-020-01235-3
?:hasPublicationType
?:journal
  • British journal of cancer
is ?:pmid of
?:pmid
?:pmid
  • 33558713
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.89
?:rankingScore_hIndex
  • 204
?:title
  • The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all